Key result
Prophylactic sac embolization during EVAR cuts early-term type II endoleaks ~80% and lowers reintervention rates.
Why the study?
The effectiveness and safety of prophylactic sac embolization during EVAR in patients with abdominal aortic aneurysms remained to be systematically investigated.
Does prophylactic intraoperative sac embolization reduce type II endoleak rates in patients undergoing EVAR for abdominal aortic aneurysms?
Meta-Analysis (n=747)
Does prophylactic intraoperative sac embolization reduce type II endoleak rates in patients undergoing EVAR for abdominal aortic aneurysms?
Prophylactic sac embolization during EVAR significantly reduces the incidence of type II endoleaks and the need for reintervention without increasing operation time.
Answers are grounded in this paper and cite their sources.
Supports prophylactic sac embolization in EVAR; extends meta-analytic evidence for reduced early endoleaks and reinterventions.
Objective We aimed to investigate the effectiveness and safety of prophylactic sac embolization during endovascular aneurysm repair (EVAR) in patients suffering from abdominal aortic aneurysms. Methods We performed a systematic literature search of PubMed, Web of Science, EMbase, Cochrane Library, China National Knowledge Infrastructure (CNKI), VIP, Wanfang and China Biomedical Literature Database (CBM) to identify studies evaluating the outcomes of sac embolization vs. no embolization among patients who had received EVAR. The time limit of the search was from the establishing database to July 22, 2022. Outcome measures involved the type II endoleak rate, the other endoleak rate, the reintervention rate, mortality, and operation time. Fixed (no heterogeneity) or random effects models were constructed for each outcome. The outcomes are represented as the odds ratio (OR) with a 95% confidence interval (CI). Results Among the 2,622 studies screened, 13 studies involving 747 participants were included in the review. The incidence of early-term type II endoleak (OR = 0.2, 95% CI (0.13,0.31), P < 0.00001), mid-term type II endoleak (OR = 0.23, 95% CI (0.15,0.37), P < 0.00001), late-term type II endoleak (OR = 0.27, 95% CI (0.16,0.46), P < 0.00001) and reintervention (OR = 0.50, 95% CI (0.37,0.78), P = 0.002) within the sac embolization group were significantly lower than those in the non-embolization group. No significant differences were observed between the two groups were found for the other endoleak rates (OR = 0.67, 95% CI (0.34,1.32), P = 0.25), mortality (OR = 0.64, 95% CI (0.25,1.66), P = 0.36) and operation time operation (MD = 5.76, 95% CI (-8.30,19.83), P = 0.42). Conclusions EVAR combined with sac embolization effectively reduces the incidence of type II endoleak and the reintervention rate without enhancing the operation time. Therefore, more high-quality studies are still needed for validation due to the limited amount and quality of included literature. Systematic Review Registration https://www.crd.york.ac.uk/PROSPERO/ , identifier: CRD42022365648.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2023) conducted a meta-analysis in abdominal aortic aneurysms (n=747). prophylactic sac embolization vs. no embolization was evaluated on early-term type II endoleak (OR 0.2, 95% CI 0.13-0.31, p=<0.00001). Prophylactic sac embolization during EVAR reduced early-term type II endoleak and reintervention rates compared to no embolization.
Synapse has enriched 10 related papers. Consider them for comparative context: